Supernus Pharmaceuticals ^{Priced, Nasdaq: SUPN}

Former Shire sub developing improved drug formulations for epilepsy and ADHD.

Industry: Health Care

First Day Return: +7.4%

SUPN

Former Shire sub developing improved drug formulations for epilepsy and ADHD.

IPO News for Supernus Pharmaceuticals

Street research for Supernus Pharmaceuticals expected on May 27 05/22/12
Supernus Pharmaceuticals prices IPO at $5, raising $50 million 05/01/12
6 US IPOs planned for the week of Apr 30 04/30/12

IPO Data
IPO Date	04/30/2012
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$50
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Headquarters	Rockville, MD, United States
Founded	2005
Employees at IPO	71
Website www.supernus.com

IPO News for Supernus Pharmaceuticals

Street research for Supernus Pharmaceuticals expected on May 27 05/22/12
Supernus Pharmaceuticals prices IPO at $5, raising $50 million 05/01/12
6 US IPOs planned for the week of Apr 30 04/30/12

Supernus Pharmaceuticals (SUPN) Performance